Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.
about
Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes.Synthesis of cholic-acid-carrying polymer and in-vitro evaluation of hepatoma-targeting nanoparticles decorated with the polymer.
P2860
Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Synthesis and in vitro evaluat ...... oxuridine to target the liver.
@ast
Synthesis and in vitro evaluat ...... oxuridine to target the liver.
@en
type
label
Synthesis and in vitro evaluat ...... oxuridine to target the liver.
@ast
Synthesis and in vitro evaluat ...... oxuridine to target the liver.
@en
prefLabel
Synthesis and in vitro evaluat ...... oxuridine to target the liver.
@ast
Synthesis and in vitro evaluat ...... oxuridine to target the liver.
@en
P2860
P1476
Synthesis and in vitro evaluat ...... oxuridine to target the liver.
@en
P2093
Diana Vivian
James E Polli
P2860
P304
P356
10.1016/J.IJPHARM.2014.09.014
P407
P577
2014-09-16T00:00:00Z